
Glymit P 2mg/500mg/15mg Tablet
Marketer
Remit Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glymit P 2mg/500mg/15mg Tablet
Combiflex-D 2mg/500mg/15mg tablets are a triple-combination medication for managing blood glucose. This formulation, used in conjunction with diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It optimizes insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex-D 2mg/500mg/15mg tablets. Administer with food to mitigate gastrointestinal discomfort. Should you miss a dose, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concomitant use with other antidiabetic agents, alcohol consumption, or skipped meals may precipitate hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, osteoporotic fractures, and upper respiratory infections. Prior to commencing treatment, inform your doctor of any pre-existing renal, hepatic, or cardiac conditions. Pregnant or lactating individuals must consult their physician before use. Your doctor will assess renal function prior to initiating therapy. Limit alcohol consumption as this may exacerbate adverse effects.
Primary Ingredients of Glymit P 2mg/500mg/15mg Tablet
The provided text is "undefined," so no rephrasing is possible.
Uses of Glymit P 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glymit P 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glymit P 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medicine with a meal.
Common Side effects of Glymit P 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glymit P 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glymit P 2mg/500mg/15mg tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.
How Glymit P 2mg/500mg/15mg Tablet works:
Glymit P 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glymit P 2mg/500mg/15mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glymit P 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glymit P 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glymit P 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glymit P 2mg/500mg/15mg tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glymit P 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Glymit P 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glymit P 2mg/500mg/15mg Tablet :
Should you forget to take a Glymit P 2mg/500mg/15mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glymit P 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
